Lombard Odier Asset Management (USA)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-246,126
| Closed | -$768K | – | 161 |
|
|
2016
Q3 | $768K | Sell |
246,126
-10,300
| -4% | -$32.1K | 0.07% | 176 |
|
|
2016
Q2 | $436K | Buy |
256,426
+7,052
| +3% | +$12K | 0.05% | 163 |
|
|
2016
Q1 | $449K | Sell |
249,374
-100,932
| -29% | -$182K | 0.06% | 138 |
|
|
2015
Q4 | $1.18M | Buy |
350,306
+33,218
| +10% | +$112K | 0.11% | 131 |
|
|
2015
Q3 | $1.69M | Buy |
317,088
+11,607
| +4% | +$61.9K | 0.15% | 144 |
|
|
2015
Q2 | $1.98M | Buy |
+305,481
| New | +$1.98M | 0.14% | 139 |
|